1 / 4

Peripheral Neuropathy Treatment Market

Global Peripheral Neuropathy Treatment Market Research Report - Global Forecast till 2025

Rohitravan
Télécharger la présentation

Peripheral Neuropathy Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Peripheral Neuropathy Market Growing prevalence of Diabetes, coupled with the Rising Geriatric Population, is Projected to Boost Market Growth at a Healthy CAGR of 3.9% During the Forecast Period of 2019 to 2025 Peripheral Neuropathy Market Highlights According to MRFR analysis, Peripheral Neuropathy Market is expected to register a CAGR of 3.9% during the forecast period of 2019 to 2025 and is expected to reach USD 292.40 Million by 2025. Peripheral neuropathy develops when nerves in the body's extremities, such as the hands, feet, and arms, are damaged. The symptoms depend on which nerves are affected. Key Players Some of the key players in the Global Peripheral Neuropathy Market are Abbott Laboratories (US), Bristol Myers Squibb (US), Novartis AG (UK), Eli Lilly and Company (US), Pfizer Inc (US), GlaxoSmithKline plc (UK), Merck and Co. Inc. (US), Cipla Limited (India), Lupin Limited (India), Dr. Reddy's Laboratories (India), F. Hoffmann-La Roche Ltd. (UK), RxFunction, Inc. (US) among others Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8485 The growth of the global peripheral neuropathy market is driven by various factors, such as increasing chemotherapy treatments for cancer and growing awareness about peripheral neuropathy. Additionally, rising innovations in the field of peripheral neuropathy by top players are also driving the market. However, stringent government regulations are projected to hamper the growth of the global peripheral neuropathy market. Several market players currently dominate the global peripheral neuropathy market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For example, in June 2015, Spinifex Pharmaceuticals acquired by Novartis. The acquisition was centered on Spinifex's EMA401, a new drug that could offer relief from chronic neuropathic pain. This acquisition helps Novartis to be a prominent player in the peripheral neuropathy market by expanding the market. Peripheral Neuropathy Market Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the rising per capita healthcare expenditure. The peripheral neuropathy market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European peripheral neuropathy market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The peripheral neuropathy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising geriatric population and the growing prevalence of diabetes, Asia-Pacific is expected to be the fastest-growing. The peripheral neuropathy market in the Middle East & Africa has been divided into the Middle East and Africa. Peripheral Neuropathy Market Segmentation The Global Peripheral Neuropathy Market has been segmented based on type, treatment, and end user. | Market Research Future |

  2. The market, based on type, has been divided into diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN), idiopathic peripheral neuropathy, and HIV/AIDS-associated peripheral neuropathy. The diabetic peripheral neuropathy (DPN)segment is likely to be the largest during the review period due to their increasing prevalence of diabetic peripheral neuropathy in youth with diabetes. The chemotherapy-induced peripheral neuropathy (CIPN) segment is predicted to be the fastest- growing due to increasing chemotherapy for the treatments of cancer patients. Many market players come up with different treatment methods and devices with advanced technologies. For instance, in June 2019, RxFunction launched sensory prosthesis for people with peripheral neuropathy. The global peripheral neuropathy market has been segregated, on the basis of treatment, into pharmacological therapies, non-pharmacological therapies, and others. The pharmacological therapies segment is expected to hold the majority share of the market owing to the pharmacological therapies are primary in the treatment of peripheral neuropathy. The non- pharmacological therapies segment is expected to be the fastest-growing due to the as non- pharmacological therapies are used along with other treatment options for neurotherapy. The end users of the market are hospitals and clinics, ambulatory centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market due to the rising awareness about advanced treatments available in the hospitals and expertise. The ambulatory centers segment is expected to be the fastest growing owing to the availability of specialized medical services and advanced medical technology Browse @ https://www.marketresearchfuture.com/reports/peripheral-neuropathy-market-8485 Full Report Details Table Of Contents 1. REPORT PROLOGUE 2. MARKET INTRODUCTION 2.1. Definition 2.2. Scope Of The Study 2.2.1. Research Objective 2.2.2. Assumptions 2.2.3. Limitations 3. RESEARCH METHODOLOGY 3.1. Overview 3.2. Primary Research 3.3. Secondary Research 3.4. Market Size Estimation 4. MARKET DYNAMICS 4.1. Overview 4.2. Drivers 4.3. Restraints 4.4. Opportunities | Market Research Future |

  3. 5. MARKET FACTOR ANALYSIS 5.1. Porter’s Five Forces Analysis 5.1.1. Bargaining Power Of Suppliers 5.1.2. Bargaining Power Of Buyers 5.1.3. Threat Of New Entrants 5.1.4. Threat Of Substitutes 5.1.5. Intensity Of Rivalry 5.2. Value Chain Analysis 6. GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET, BY TYPE 6.1. Overview 6.2. Diabetic Peripheral Neuropathy (DPN) Market Estimates & Forecast, By Region, 2019–2025 Market Estimates & Forecast, By Country, 2019–2025 6.3. Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Estimates & Forecast, By Region, 2019–2025 Market Estimates & Forecast, By Country, 2019–2025 6.4. Idiopathic Peripheral Neuropathy Market Estimates & Forecast, By Region, 2019–2025 Market Estimates & Forecast, By Country, 2019–2025 6.5. HIV/AIDS Associated Peripheral Neuropathy Market Estimates & Forecast, By Region, 2019–2025 Market Estimates & Forecast, By Country, 2019–2025 7. GLOBAL PERIPHERAL NEUROPATHY TREATMENT MARKET, BY TREATMENT 7.1. Overview 7.2. Pharmacological Therapies Continued… About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: | Market Research Future |

  4. Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com | Market Research Future |

More Related